Here, gain- and loss-of-experiments and a series of in vitro and in vivo assays illustrated that NMT1 overexpression contributes to HCC cancer progression through the myristoylation of downstream substrates and the activation of key signaling pathways. This evidence concerns the gene NMT1 and hepatocellular carcinoma.